Accession Number : AD1033291


Title :   Theranostics Targeting Metastatic Breast Cancer


Descriptive Note : Technical Report,30 Sep 2015,29 Sep 2016


Corporate Author : Texas A and M University College Station United States


Personal Author(s) : Burgess,Kevin


Full Text : https://apps.dtic.mil/dtic/tr/fulltext/u2/1033291.pdf


Report Date : 01 Oct 2016


Pagination or Media Count : 111


Abstract : This application is designed to impact three of the overarching challenges identified for this award type: (i) revolutionary treatment regimes replacing drugs that have life-threatening toxicities with safe and effective interventions; (ii) elimination of mortality associated with metastatic breast cancer; and, (iii) distinguishing aggressive breast cancer from indolent forms, to avoid over-diagnosis and treatment. Overall, this work addresses issues that relate to: (i) revolutionary treatment regimes replacing drugs that have life-threatening toxicities with safe and effective interventions; (ii) elimination of mortality associated with metastatic breast cancer; and, (iii) distinguishing aggressive breast cancer from indolent forms, to avoid over-diagnosis and treatment.


Descriptors :   PERSONALIZED MEDICINE , breast cancer , REAGENTS , histology , neoplasms , positron emission tomography


Subject Categories : Medicine and Medical Research
      Biochemistry


Distribution Statement : APPROVED FOR PUBLIC RELEASE